These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3935159)

  • 1. Kinetic mechanisms of two NAD:arginine ADP-ribosyltransferases: the soluble, salt-stimulated transferase from turkey erythrocytes and choleragen, a toxin from Vibrio cholerae.
    Osborne JC; Stanley SJ; Moss J
    Biochemistry; 1985 Sep; 24(19):5235-40. PubMed ID: 3935159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid specific ADP-ribosylation: specific NAD: arginine mono-ADP-ribosyltransferases associated with turkey erythrocyte nuclei and plasma membranes.
    West RE; Moss J
    Biochemistry; 1986 Dec; 25(24):8057-62. PubMed ID: 3099839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of an NAD:arginine ADP-ribosyltransferase by histone.
    Moss J; Stanley SJ; Osborne JC
    J Biol Chem; 1982 Feb; 257(4):1660-3. PubMed ID: 6799512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor.
    Moss J; Vaughan M
    J Biol Chem; 1977 Apr; 252(7):2455-7. PubMed ID: 139409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of glutamine synthetases by an NAD:arginine ADP-ribosyltransferase.
    Moss J; Watkins PA; Stanley SJ; Purnell MR; Kidwell WR
    J Biol Chem; 1984 Apr; 259(8):5100-4. PubMed ID: 6143754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the GTPase activity of transducin by an NAD+:arginine ADP-ribosyltransferase from turkey erythrocytes.
    Watkins PA; Kanaho Y; Moss J
    Biochem J; 1987 Dec; 248(3):749-54. PubMed ID: 2829839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of NAD: arginine ADP-ribosyltransferases in animal tissues.
    Moss J; Watkins PA; Yost DA
    Princess Takamatsu Symp; 1983; 13():103-9. PubMed ID: 6418712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of choleragen.
    Vaughan M; Moss J
    J Supramol Struct; 1978; 8(4):473-88. PubMed ID: 214641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of an avian erythrocyte protein possessing ADP-ribosyltransferase activity and capable of activating adenylate cyclase.
    Moss J; Vaughan M
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3621-4. PubMed ID: 211502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of choleragen ADP-ribosyltransferase activities by guanyl nucleotides and a 19-kDa membrane protein.
    Tsai SC; Noda M; Adamik R; Moss J; Vaughan M
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5139-42. PubMed ID: 3110784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid-specific ADP-ribosylation. Evidence for two distinct NAD:arginine ADP-ribosyltransferases in turkey erythrocytes.
    Yost DA; Moss J
    J Biol Chem; 1983 Apr; 258(8):4926-9. PubMed ID: 6403540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the ADP-ribosyltransferase and NAD glycohydrolase activities of a mammalian transferase (ADP-ribosyltransferase 5) by auto-ADP-ribosylation.
    Weng B; Thompson WC; Kim HJ; Levine RL; Moss J
    J Biol Chem; 1999 Nov; 274(45):31797-803. PubMed ID: 10542202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of mammalian ADP-ribosylation cycles.
    Okazaki IJ; Zolkiewska A; Takada T; Moss J
    Biochimie; 1995; 77(5):319-25. PubMed ID: 8527484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversibility of arginine-specific mono(ADP-ribosyl)ation: identification in erythrocytes of an ADP-ribose-L-arginine cleavage enzyme.
    Moss J; Jacobson MK; Stanley SJ
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5603-7. PubMed ID: 2994036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of adenylate cyclase by heat-labile Escherichia coli enterotoxin. Evidence for ADP-ribosyltransferase activity similar to that of choleragen.
    Moss J; Richardson SH
    J Clin Invest; 1978 Aug; 62(2):281-5. PubMed ID: 209060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid-specific ADP-ribosylation.
    Moss J; Yost DA; Stanley SJ
    J Biol Chem; 1983 May; 258(10):6466-70. PubMed ID: 6304041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone-dependent and histone-independent forms of an ADP-ribosyltransferase from human and turkey erythrocytes.
    Moss J; Stanley SJ
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4809-12. PubMed ID: 6272274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of ADP-ribose from NAD to choleragen: a subunit acts as catalyst and acceptor protein.
    Trepel JB; Chuang DM; Neff NH
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5440-2. PubMed ID: 202956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein).
    Moss J; Stanley SJ; Burns DL; Hsia JA; Yost DA; Myers GA; Hewlett EL
    J Biol Chem; 1983 Oct; 258(19):11879-82. PubMed ID: 6311827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of the 24 kDa substrate for botulinum C3 ADP-ribosyltransferase and the cholera toxin ADP-ribosylation factor.
    Tsai SC; Adamik R; Moss J; Aktories K
    Biochem Biophys Res Commun; 1988 May; 152(3):957-61. PubMed ID: 3132159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.